Managed Account Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | $680K | Sell |
5,672
-2,049
| -27% | -$246K | ﹤0.01% | 2223 |
|
|
2015
Q1 | $806K | Sell |
7,721
-1,612
| -17% | -$168K | ﹤0.01% | 2151 |
|
|
2014
Q4 | $906K | Sell |
9,333
-17,681
| -65% | -$1.72M | ﹤0.01% | 2089 |
|
|
2014
Q3 | $2.11M | Buy |
27,014
+23,235
| +615% | +$1.81M | ﹤0.01% | 1785 |
|
|
2014
Q2 | $239K | Sell |
3,779
-3,189
| -46% | -$202K | ﹤0.01% | 2264 |
|
|
2014
Q1 | $468K | Buy |
6,968
+2,235
| +47% | +$150K | ﹤0.01% | 2111 |
|
|
2013
Q4 | $304K | Buy |
4,733
+1,107
| +31% | +$71.1K | ﹤0.01% | 2136 |
|
|
2013
Q3 | $232K | Sell |
3,626
-977
| -21% | -$62.5K | ﹤0.01% | 2116 |
|
|
2013
Q2 | $143K | Buy |
+4,603
| New | +$143K | ﹤0.01% | 2187 |
|